[Form 4] Salesforce, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Marc Benioff, Chair and CEO of Salesforce, Inc. (CRM), exercised 2,250 non‑qualified stock options at an exercise price of $161.50 on 10/01/2025 and simultaneously sold 2,250 shares in multiple transactions on the same date at weighted average prices that fall within ranges reported in the filing. After these transactions the reporting person directly beneficially owned approximately 11.91 million shares and indirectly held an additional 10.107 million shares via trust and the Marc Benioff Fund LLC.

The filing notes the trades were effected automatically under a Rule 10b5‑1 trading plan adopted on 01/09/2025. The option exercised vests over a four‑year schedule with the grant date of 03/22/2020 and the option expires on 03/22/2026. The Form 4 is signed by an attorney‑in‑fact on behalf of Mr. Benioff.

Positive

• 2,250 options exercised at $161.50, converting to common stock
• Trades were effected under a Rule 10b5‑1 trading plan adopted on 01/09/2025
• Reporting person retains substantial holdings: roughly 11.91M direct plus 10.107M indirect shares

Negative

• Reported sale of 2,250 shares by the CEO on 10/01/2025, which may be perceived as insider selling

Insights

Corporate Governance Analyst

Insider executed an option exercise and matched sales under a 10b5‑1 plan.

The filing shows an exercise of 2,250 options at $161.50 and concurrent sale of 2,250 shares on 10/01/2025. This pattern is consistent with liquidity actions executed under a predetermined trading plan rather than ad‑hoc sales.

Because the report discloses continued indirect holdings via trusts and the Marc Benioff Fund LLC totaling over 10 million shares, the exercise and sales did not materially reduce the reporting person’s overall economic exposure as disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Benioff Marc

(Last) (First) (Middle)

415 MISSION STREET

3RD FLOOR

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Salesforce, Inc. [ CRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		M(1)		2,250	A	$161.5	11,913,821	D(2)
Common Stock	10/01/2025		S(1)		553	D	$234.1952(3)	11,913,268	D(2)
Common Stock	10/01/2025		S(1)		517	D	$235.0092(4)	11,912,751	D(2)
Common Stock	10/01/2025		S(1)		504	D	$236.144(5)	11,912,247	D(2)
Common Stock	10/01/2025		S(1)		176	D	$236.9734(6)	11,912,071	D(2)
Common Stock	10/01/2025		S(1)		97	D	$238.4856(7)	11,911,974	D(2)
Common Stock	10/01/2025		S(1)		279	D	$240.3524(8)	11,911,695	D(2)
Common Stock	10/01/2025		S(1)		124	D	$241.4073(9)	11,911,571	D(2)
Common Stock								107,000	I	By Trust
Common Stock								10,000,000	I(10)	By Marc Benioff Fund LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)	$161.5	10/01/2025		M(1)			2,250	03/22/2020(11)	03/22/2026	Common Stock	2,250	$0	49,622	D

Explanation of Responses:

1. As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

2. Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

3. Weighted average price. These shares were sold in multiple transactions at prices ranging from $233.7018 to $234.6900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

4. Weighted average price. These shares were sold in multiple transactions at prices ranging from $234.7000 to $235.6900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

5. Weighted average price. These shares were sold in multiple transactions at prices ranging from $235.7000 to $236.6521 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

6. Weighted average price. These shares were sold in multiple transactions at prices ranging from $236.7300 to $237.3300 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

7. Weighted average price. These shares were sold in multiple transactions at prices ranging from $238.3106 to $238.6643 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

8. Weighted average price. These shares were sold in multiple transactions at prices ranging from $239.9326 to $240.6931 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

9. Weighted average price. These shares were sold in multiple transactions at prices ranging from $241.2801 to $241.6793 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

10. Shares held in the Marc Benioff Fund LLC (the "Fund"). Fund interests are held in the reporting person's name or in trust.

11. Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

	/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Marc Benioff report on the Form 4 for CRM?

The Form 4 reports Mr. Benioff exercised 2,250 options at $161.50 and sold 2,250 shares on 10/01/2025 under a Rule 10b5‑1 plan.

How many shares does Marc Benioff beneficially own after the transactions?

The filing shows approximately 11.91 million shares directly and an additional 10.107 million shares held indirectly via trust and the Marc Benioff Fund LLC.

Were the trades part of a preplanned program?

Yes. The filing states the transactions were effected automatically under a Rule 10b5‑1 trading plan adopted on 01/09/2025.

What were the sale prices reported for the shares sold?

The filing reports sales across multiple transactions with weighted average prices and price ranges; individual tranches ranged approximately from $233.7018 to $241.6793.

When do the exercised options expire and how did they vest?

The options reference a grant date of 03/22/2020, vesting 25% on the first anniversary and monthly thereafter, with an expiration on 03/22/2026.